In SS vs. NASH group, the AUC of JUN and CCL20 were 0.7579 and 0.8421, respectively, however, the combined diagnostic efficacy of the two genes was not improved (AUC: 0.8289) (Figure 7D). The gene discussed is CCL20; the disease is synovial sarcoma.